Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Classificação em ações #25842
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Preço da ação
$0.40861751
Valor de mercado
$45.81M
Variação (1 dia)
-1.15%
Variação (1 ano)
-46.41%
País
TW
Negociar TaiRx, Inc. (6580)

Categoria

Histórico de preços das ações de TaiRx, Inc. (6580)
Preço de fecho mais alto: $0.42 em 2026-08-01

Preço de fecho mais baixo: $1.41 em 2017-06-01
Histórico de preços das ações da TaiRx, Inc. de 2017 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -13.06%
2025 -14.32%
2024 -0.12%
2023 -32.09%
2022 -18.00%
2021 52.04%
2020 57.15%
2019 -14.81%
2018 -18.47%
2017 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US